24 Megakaryocytes (MKs) are precursors to platelets, the second most abundant cells in the 25 peripheral circulation. However, while platelets are known participate in immune responses and 26 play significant roles during infections, the role of MKs within the immune system has not been 27 explored. Here we utilize in vitro techniques to show that both cord blood-derived MKs (CB 28 MKs) and MKs from a human megakaryoblastic leukemia cell line (Meg-01) chemotax towards 29 pathogenic stimuli, phagocytose bacteria, and release chromatin webs in response to bacteria.
9 153 subdividing the sepsis patient population by the source of the infection, patients with gram negative 154 bacterial infections (n = 3) had significantly higher MK counts compared to those with gram 155 positive bacterial infections (n = 7) (p < 0.01) but not those with the mixed infections (n = 3) (p = 156 0.13) (15070 ± 5158 MK/mL, 5140 ± 2082 MK/mL, 10146 ± 7675 MK/mL, respectively) ( Figure   157 4Biii) . 158 159 Automated analyzers fail to identify circulating MKs 160 We tested whether standard automated blood counting methods could identify circulating MKs 161 ( Figure S1) . In an automated CBC analyzer, pure CB MKs were detected and categorized as an 162 unknown type of white blood cells (WBCs) with an error notification. However, when CB MKs 163 were spiked into whole blood samples, the automated analyzer categorized the additional cells as 164 neutrophils, measured a corresponding increase in the WBC numbers, and did not display an error 165 message (Figure S1D) . Meg-01 cells could not be counted or analyzed accurately by the 166 automated analyzer, neither as a pure population nor when spiked into whole blood. This is likely 167 due to the differences in size between these two populations. While CB MKs are 10-30 µm and 168 resemble small, granular lymphocytes on light microscopy, Meg-01 cells range from 15-75 µm 169 and are often found in large clusters.
171 Large numbers of circulating MKs correlate with worse prognosis in sepsis patients
172 To investigate whether MK enumeration in the circulation might be used to predict prognosis, we 173 analyzed samples from three sepsis patients at 2 time-points during their hospital stay. We 174 observed a decrease in circulating MKs in the patient that recovered and was discharged from the 175 hospital, as compared to the two patients that remained in the hospital for multiple weeks and 176 developed AKI (Figure 4Biv ). Platelet count did not significantly differ in sepsis versus control 177 patients (p = 0.98; 251.1 ± 207.6 plt x 10^6/mL and 253.6 ± 34.5 plt x 10^6/mL, respectively), 178 whereas there was a significant difference between sepsis and control patients in total white blood 179 cell counts (p = 0.015; 14.7 ± 9.6 WBC x 10^6/mL and 5.2 ± 1.1 WBC x 10^6/mL, respectively).
180 There was no correlation between circulating MKs and platelet or white blood cell count ( Figure   181 S7) . Interestingly, the circulating CD61 + CD41 + Draq5 + cells identified in the patient samples were 182 CD162 -, which may indicate that adult MKs have a different surface phenotype to neonatal MKs, 183 which are CD162 + (Figure S2) . Preliminary experiments aimed at identifying circulating MKs in 184 neonatal intensive care unit (NICU) patients revealed that cells from these children appeared to be 185 both CD34 + and CD162 + in addition to being CD41 + Draq5 + (data not shown), suggesting that 186 circulating MK phenotype may vary with the age of the patient. While the sample size in this 187 exploratory study is too small to draw definitive conclusions, these data suggest that circulating 188 MKs should be further explored in the context of sepsis-related complications. 197 Comparing H&E stained sections to corresponding CD61 IHC image showed that although MKs 198 could generally be identified on H&E by their large, darkly-stained nucleus, this was not always 13 226 DISCUSSION 227 We found that MK cells display several immune cell functions, including chemotaxis, 228 phagocytosis, and the release of histone-decorated chromatin webs, besides the traditional role in 229 the production of platelets 2 . We demonstrate that, not only do MKs internalize bacteria, but they 230 also localize the bacteria to acidified, lysosomal-type granules, which is indicative of an active 231 killing process 44, 45 . Our finding complements earlier observations that MKs contain various 232 intracellular pathogens, including dengue virus, human immunodeficiency virus, and aspergillus 26-233 29 . The MK immune function complements earlier reports for platelets being 'first responders' to 234 microbes and inflammatory insults, stimulating the recruitment and activation of white blood cells, 235 and even directly trapping pathogens themselves [41] [42] [43] . We also found that that Meg-01 cells 236 undergo active chemotaxis towards common inflammatory stimuli 35 and can migrate through 237 channels with cross section smaller than 50 m 2 . This size is comparable to that of small capillary 238 vessels our observation raises the possibility that MKs are not 'trapped' in microcirculatory beds, 239 but instead they may move through and diapedese into surrounding tissues where they participate 240 in inflammation and regeneration 3,47-51 . Additionally, the observed directional budding of platelets 241 into the channels containing the chemotactic agent and "obstruction" of the channels by MKs and 242 platelets and/or vesicles, suggest an ability to contribute to decreased blood flow within small 243 capillary vessels 10,43,52-55 .
245
We also demonstrate that MKs can release intracellular contents and generate chromatin webs. 
